Adam Sherwat
- Infectious Diseases top 10%
- Virology top 5%
- Epidemiology
- Molecular Biology
- Hepatology
- Co-authors
- Kirk M. Chan‐TackDebra BirnkrantJohn FarleyDaniel B. RubinPeter KimJohn T. BrooksPatrick R. HarringtonJulian J. O’Rear
- Topics
- HIV/AIDS drug development and treatment (4 papers)Pharmacological Effects and Toxicity Studies (3 papers)Bacillus and Francisella bacterial research (2 papers)
- Partner nations
- United StatesThailandCanada
In The Last Decade
Adam Sherwat
11 papers receiving 389 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Infectious Diseases 171
- Virology 164
- Epidemiology 163
- Molecular Biology 152
- Hepatology 48
Countries citing papers authored by Adam Sherwat
This map shows the geographic impact of Adam Sherwat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Sherwat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Sherwat more than expected).
Fields of papers citing papers by Adam Sherwat
This network shows the impact of papers produced by Adam Sherwat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Sherwat. The network helps show where Adam Sherwat may publish in the future.
Co-authorship network of co-authors of Adam Sherwat
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Sherwat. A scholar is included among the top collaborators of Adam Sherwat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Sherwat. Adam Sherwat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerationsbreakdown → | 121 |
| 3 | 133 | |
| 4 | 28 | |
| 5 | 25 | |
| 6 | 3 | |
| 7 | 10 | |
| 8 | 9 | |
| 9 | 42 | |
| 10 | 15 | |
| 11 | 10 |
About Adam Sherwat
Adam Sherwat is a scholar working on Virology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 11 papers that have together received 397 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Bacillus and Francisella bacterial research (2 papers). The work is most often cited by research in Virology (164 citations), Infectious Diseases (171 citations) and Hepatology (48 citations). Adam Sherwat has collaborated with scholars based in United States, Thailand and Canada. Frequent co-authors include Kirk M. Chan‐Tack, Debra Birnkrant, John Farley, Daniel B. Rubin, Peter Kim, John T. Brooks, Patrick R. Harrington, Julian J. O’Rear, LaRee Tracy and Takashi Komatsu. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.